Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T B Horvath

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Advances in Experimental Medicine and Biology|January 1, 1980
Acute and chronic effects of ethanol on event-related potentialsA Pfefferbaum, T B Horvath, W T Roth, et al.
Archives of General Psychiatry|April 1, 1994
Familial correlates of reduced central serotonergic system function in patients with personality disordersE F Coccaro, J M Silverman, H M Klar, et al.
Journal of Psychosomatic Research|January 1, 1976
Mood states and 24-hour cardiac monitoringW T Roth, J R Tinklenberg, C M Doyle, et al.
Drug and Alcohol Dependence|May 1, 1991
Levels of opioid physical dependence in heroin addictsP D Kanof, M J Aronson, R Ness, et al.
The American Journal of Psychiatry|April 1, 1987
Induction of depression with oxotremorine in patients with Alzheimer's diseaseK L Davis, E Hollander, M Davidson, et al.
Psychiatry Research|October 1, 1985
Apomorphine has no effect on plasma homovanillic acid in schizophrenic patientsM Davidson, K S Kendler, B M Davis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1991
Neuroleptics improve sustained attention in schizophrenia. A study using signal detection theoryP G Nestor, S F Faux, R W McCarley, et al.
Psychopharmacology Bulletin|October 1, 1982
Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's typeK L Davis, J Y Hsieh, M I Levy, et al.
Biological Psychiatry|September 1, 1987
RS 86 in the treatment of Alzheimer's disease: cognitive and biological effectsE Hollander, M Davidson, R C Mohs, et al.
Psychopharmacology Bulletin|January 1, 1986
Physostigmine in patients with Alzheimer's diseaseM Davidson, R C Mohs, E Hollander, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Advances in Experimental Medicine and Biology|January 1, 1980
Acute and chronic effects of ethanol on event-related potentialsA Pfefferbaum, T B Horvath, W T Roth, et al.
Archives of General Psychiatry|April 1, 1994
Familial correlates of reduced central serotonergic system function in patients with personality disordersE F Coccaro, J M Silverman, H M Klar, et al.
Journal of Psychosomatic Research|January 1, 1976
Mood states and 24-hour cardiac monitoringW T Roth, J R Tinklenberg, C M Doyle, et al.
Drug and Alcohol Dependence|May 1, 1991
Levels of opioid physical dependence in heroin addictsP D Kanof, M J Aronson, R Ness, et al.
The American Journal of Psychiatry|April 1, 1987
Induction of depression with oxotremorine in patients with Alzheimer's diseaseK L Davis, E Hollander, M Davidson, et al.
Psychiatry Research|October 1, 1985
Apomorphine has no effect on plasma homovanillic acid in schizophrenic patientsM Davidson, K S Kendler, B M Davis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 1, 1991
Neuroleptics improve sustained attention in schizophrenia. A study using signal detection theoryP G Nestor, S F Faux, R W McCarley, et al.
Psychopharmacology Bulletin|October 1, 1982
Cerebrospinal fluid acetylcholine, choline, and senile dementia of the Alzheimer's typeK L Davis, J Y Hsieh, M I Levy, et al.
Biological Psychiatry|September 1, 1987
RS 86 in the treatment of Alzheimer's disease: cognitive and biological effectsE Hollander, M Davidson, R C Mohs, et al.
Psychopharmacology Bulletin|January 1, 1986
Physostigmine in patients with Alzheimer's diseaseM Davidson, R C Mohs, E Hollander, et al.
Pageof 5